Related Experiment Video
Updated: Jun 28, 2026
10:17
Efficient Construction of Drug-like Bispirocyclic Scaffolds Via Organocatalytic Cycloadditions of α-Imino γ-Lactones and Alkylidene Pyrazolones
Published on: February 7, 2019
Structural analysis of spiro beta-lactone proteasome inhibitors
Michael Groll1, Emily P Balskus, Eric N Jacobsen
1Center for Integrated Protein Science at the Department Chemie, Lehrstuhl für Biochemie, Technische Universität München, Lichtenbergstrasse 4, D-85747 Garching, Germany.
Journal of the American Chemical Society
|October 22, 2008
Summary
Researchers developed novel spiro beta-lactone proteasome inhibitors inspired by (+)-lactacystin. One compound potently inhibited the 26S proteasome, while its epimer showed weak activity, offering insights into drug design.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Organic Synthesis
Background:
- The proteasome is a crucial cellular machine involved in protein degradation.
- Developing potent and selective proteasome inhibitors is a key goal in drug discovery, particularly for cancer therapy.
- Natural products like (+)-lactacystin serve as valuable scaffolds for designing novel therapeutic agents.
Purpose of the Study:
- To synthesize and evaluate novel spiro beta-lactone-based compounds as proteasome inhibitors.
- To elucidate the structural basis for differential inhibition of the proteasome by stereoisomers.
- To understand the mechanism of action and structure-activity relationships of these inhibitors.
Main Methods:
- Asymmetric catalytic total synthesis of (+)-lactacystin and its analogues.
- In vitro assays to determine proteasome inhibitory activity (e.g., 26S proteasome inhibition).
- X-ray crystallography to determine the structures of inhibitor-proteasome complexes (20S proteasome).
Main Results:
- Spiro beta-lactone derivative 4 demonstrated potent inhibition of the 26S proteasome.
- The C-6 epimer, lactone 5, exhibited significantly weaker proteasome inhibitory activity.
- Crystallographic analysis revealed distinct interactions between inhibitors 4 and 5 and the catalytic threonine residue of the proteasome.
- Differences in hydrolytic stability of the acyl-enzyme complexes were proposed as the reason for potency variation.
Conclusions:
- Spiro beta-lactone scaffolds are promising for developing potent proteasome inhibitors.
- Stereochemistry plays a critical role in the potency and mechanism of proteasome inhibition.
- Structural insights from crystallography are vital for understanding inhibitor-proteasome interactions and guiding future drug design.
Related Concept Videos
01:17The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
02:33Stereoisomerism of Cyclic Compounds
In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...